Catalyst
Slingshot members are tracking this event:
Opko Biologics (OPKO) Phase 1 study to evaluate safety and efficacy of VIIa (MOD-5014) in males
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| OPK |
|
|
||||
Additional Information
• Phase 2a trial for intravenously administered Factor VII-CTP and Phase 1 trial for subcutaneously administered Factor VII-CTP ongoing.
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 04, 2018
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT02919800?term=opko
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Vlla
